WallStreetZenWallStreetZen

NASDAQ: NLSP
Nls Pharmaceutics Ltd Stock Ownership - Who owns Nls Pharmaceutics?

Insider buying vs selling

Have Nls Pharmaceutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NLSP insiders and whales buy or sell their stock.

NLSP Shareholders

What type of owners hold Nls Pharmaceutics Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc16.11%5,747,126$948.28kInstitution
Wells Fargo Company0.16%56,549$9.33kInstitution
Geode Capital Management LLC0.04%14,362$2.37kInstitution
Renaissance Technologies LLC0.04%12,677$2.09kInstitution
Bank Of America Corp0.00%90$14.85Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

NLSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NLSP16.35%0.00%
PULM4.28%95.72%
BRTX0.28%99.72%Net BuyingNet Buying
ATXI0.73%14.82%Net Buying
SNGX0.36%99.64%

Nls Pharmaceutics Stock Ownership FAQ

Who owns Nls Pharmaceutics?

Nls Pharmaceutics (NASDAQ: NLSP) is owned by 16.35% institutional shareholders, 0.00% Nls Pharmaceutics insiders, and 83.65% retail investors. Bvf Inc is the largest individual Nls Pharmaceutics shareholder, owning 5.75M shares representing 16.11% of the company. Bvf Inc's Nls Pharmaceutics shares are currently valued at $1.03M.

If you're new to stock investing, here's how to buy Nls Pharmaceutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.